Trousseau's syndrome -: what is the evidence?: A population-based autopsy study

被引:75
作者
Ögren, M
Bergqvist, D
Wählander, K
Eriksson, H
Sternby, NH
机构
[1] Univ Uppsala Hosp, Dept Vasc Surg, SE-75185 Uppsala, Sweden
[2] Sahlgrens Univ Hosp, Dept Med, S-41345 Gothenburg, Sweden
[3] Lund Univ, Malmo Univ Hosp, Dept Pathol, Malmo, Sweden
关键词
clinical/epidemiological studies; malignancy; pulmonary embolism;
D O I
10.1160/TH-05-10-0694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite numerous studies documenting the association between cancer and venous thromboembolism (VTE), the reason for the excessive risk in certain cancers remains obscure. No large-scale studies have yet investigated the independent effects of cancer type, site and growth pattern. Between 1970 and 1982, 23,796 standardised autopsies were performed, representing 84% of all in-hospital deaths in an urban Swedish population. The relationship between cancer and PE was evaluated with logistic regression. The overall PE prevalence was 23%, and 10% of the population had a fatal PE. Forty-two per cent of pancreatic cancer patients had PE (OR 2.55; 95% CI 2.10-3.09) (p < 0.001); gall bladder, gastric, colorectal and pulmonary adenocarcinomas were similarly independently associated with PE. In comparison with squamous cell lung cancer, patients with pulmonary adenocarcinoma had 1.65 times higher odds for PE (95% CI 1.20-2.29). Adenocarcinoma and metastatic cancer were independently associated with PE risk (OR 1.27; 95% CI 1.16 - 1.40; P < 0.001, and OR 1.10; 95% CI 1.01 - 1.20; p=0.024, respectively) but when controlling for cancer type and spread, pancreatic cancer was still associated with an OR of 2.10 (95% CI 1.71-2.58) of PE (p < 0.001).We conclude that the risk of PE in cancer patients depends not only on the cancer site and spread but also on the histological type. The excess independent risk in pancreatic cancer is intriguing and should warrant further research.
引用
收藏
页码:541 / 545
页数:5
相关论文
共 23 条
[1]   Incidence of acute thrombo-embolic occlusion of the superior mesenteric artery -: A population-based study [J].
Acosta, S ;
Ögren, M ;
Sternby, NH ;
Bergqvist, D ;
Björck, M .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2004, 27 (02) :145-150
[2]   A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer [J].
Altinbas, M ;
Coskun, HS ;
Er, O ;
Ozkan, M ;
Eser, B ;
Unal, A ;
Cetin, M ;
Soyuer, S .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (08) :1266-1271
[3]   Venous thromboembolism and cancer [J].
Baron, JA ;
Gridley, G ;
Weiderpass, E ;
Nyrén, O ;
Linet, M .
LANCET, 1998, 351 (9109) :1077-1080
[4]  
Baron JA, 2000, LANCET, V355, P758
[5]   The incidence of occult cancer in patients with deep venous thrombosis: A prospective study [J].
Bastounis, EA ;
Karayiannakis, AJ ;
Makri, GG ;
Alexiou, D ;
Papalambros, EL .
JOURNAL OF INTERNAL MEDICINE, 1996, 239 (02) :153-156
[6]   A 30-YEAR SURVEY OF PULMONARY-EMBOLISM VERIFIED AT AUTOPSY - AN ANALYSIS OF 1274 SURGICAL PATIENTS [J].
BERGQVIST, D ;
LINDBLAD, B .
BRITISH JOURNAL OF SURGERY, 1985, 72 (02) :105-108
[7]   The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma [J].
Blom, JW ;
Osanto, S ;
Rosendaal, FR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (10) :1760-1765
[8]  
Falanga A, 1998, HAEMOSTASIS, V28, P50
[9]   OCCULT CANCER IN PATIENTS WITH ACUTE PULMONARY-EMBOLISM [J].
GORE, JM ;
APPELBAUM, JS ;
GREENE, HL ;
DEXTER, L ;
DALEN, JE .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) :556-560
[10]   DEEP VENOUS THROMBOSIS AND PULMONARY-EMBOLISM - RISK OF SUBSEQUENT MALIGNANT NEOPLASMS [J].
GRIFFIN, MR ;
STANSON, AW ;
BROWN, ML ;
HAUSER, MF ;
OFALLON, WM ;
ANDERSON, HM ;
KAZMIER, FJ ;
MELTON, LJ .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (11) :1907-1911